Medicenna Presents Preclinical Data from its Anti-PD1-IL-2 BiSKIT and IL-2 Super Agonist Programs at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
November 08, 2024 10:00 ET | Source: Medicenna Therapeutics Corp. MDNA113…
Search
Have an existing account?
Sign In
Tag: medicenna